Patient and transplant characteristics
Characteristics . | No. . |
|---|---|
| Total patients | 88 |
| Men/women | 66/22 |
| Median age at transplantation, y (range) | 48 (18-73) |
| Histology at diagnosis | |
| Indolent/LG-NHL | 41 |
| Follicular NHL | 29 |
| Lymphopiasmacytoid NHL | 3 |
| CLL/prolymphocytic leukemia | 9 |
| MCL | 10 |
| Aggressive/HG-NHL | 37 |
| Peripheral T-cell NHL | 4 |
| Transformed low-grade NHL | 11 |
| Diffuse large B-cell lymphoma | 22 |
| Previous chemotherapy regimens, median (range) | 3 (1-6) |
| Previous autograft (%) | |
| Total | 37 (42) |
| LG-NHL | 15 (37) |
| MCL | 4 (40) |
| HG-NHL | 19 (51) |
| Disease status at transplantation | |
| LG-NHL | |
| CR | 11 |
| Stable PR | 29 |
| Ref/prog disease | 1 |
| MCL | |
| CR | 4 |
| Stable PR | 5 |
| Ref/prog disease | 1 |
| HG-NHL | |
| CR | 6 |
| Stable PR | 23 |
| Ref/prog disease | 8 |
| Donor | |
| HLA-identical related | 63 |
| 1 antigen-mismatch related | 2 |
| Matched unrelated | 17 |
| 1 antigen-mismatch unrelated | 6 |
| Stem cell source | |
| PBSC | 63 |
| PBSC + BM | 1 |
| BM | 24 |
| CMV serostatus, donor/recipient | |
| Negative/negative | 34 |
| Negative/positive | 19 |
| Positive/negative | 10 |
| Positive/positive | 25 |
Characteristics . | No. . |
|---|---|
| Total patients | 88 |
| Men/women | 66/22 |
| Median age at transplantation, y (range) | 48 (18-73) |
| Histology at diagnosis | |
| Indolent/LG-NHL | 41 |
| Follicular NHL | 29 |
| Lymphopiasmacytoid NHL | 3 |
| CLL/prolymphocytic leukemia | 9 |
| MCL | 10 |
| Aggressive/HG-NHL | 37 |
| Peripheral T-cell NHL | 4 |
| Transformed low-grade NHL | 11 |
| Diffuse large B-cell lymphoma | 22 |
| Previous chemotherapy regimens, median (range) | 3 (1-6) |
| Previous autograft (%) | |
| Total | 37 (42) |
| LG-NHL | 15 (37) |
| MCL | 4 (40) |
| HG-NHL | 19 (51) |
| Disease status at transplantation | |
| LG-NHL | |
| CR | 11 |
| Stable PR | 29 |
| Ref/prog disease | 1 |
| MCL | |
| CR | 4 |
| Stable PR | 5 |
| Ref/prog disease | 1 |
| HG-NHL | |
| CR | 6 |
| Stable PR | 23 |
| Ref/prog disease | 8 |
| Donor | |
| HLA-identical related | 63 |
| 1 antigen-mismatch related | 2 |
| Matched unrelated | 17 |
| 1 antigen-mismatch unrelated | 6 |
| Stem cell source | |
| PBSC | 63 |
| PBSC + BM | 1 |
| BM | 24 |
| CMV serostatus, donor/recipient | |
| Negative/negative | 34 |
| Negative/positive | 19 |
| Positive/negative | 10 |
| Positive/positive | 25 |
Prog/ref disease indicates progressive or refractory disease.